The device can print out 18 different biodegradable biomaterial implant models that can either regenerate or reconstruct defects due to trauma or craniomaxillofacial reconstructive surgery and is easy to shape during operation while having few side effects.
The sales approval in Thailand came after the company got a regulatory nod for the same device in Vietnam in January. T&R Biofab plans to speed up marketing in Southeast Asia following the go-ahead from the two nations.
“Following the acquisition of a license in Vietnam and Thailand, the company expects to accelerate the expansion of its 3D printing medical device in the related markets,” a company official said. “Thailand is the second-largest market for medical technology in the ASEAN market, followed by Singapore while having the eighth largest medical device market in the Asia-Pacific region.”
<© Korea Biomedical Review, All rights reserved.>